ReviewRadiation oncology (London, England)2011

Antiangiogenic agents in the treatment of recurrent or newly diagnosed glioblastoma: analysis of single-agent and combined modality approaches.

Kathryn Beal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.